465.0251
Generic drugs; removal from formulary under specified circumstances.
Find cases:
SyfertCases citing this section
FL-LEGleg.state.fl.us
JustiaFla. Statutes
CornellLII Search
CasesGoogle Scholar
465.0251 Generic drugs; removal from formulary under specified circumstances.—
(1) The Board of Pharmacy and the Board of Medicine shall remove any generic named drug product from the formulary established by s. 465.025(6), if every commercially marketed equivalent of that drug product is “A” rated as therapeutically equivalent to a reference listed drug or is a reference listed drug as referred to in “Approved Drug Products with Therapeutic Equivalence Evaluations” (Orange Book) published by the United States Food and Drug Administration.
(2) Nothing in this act shall alter or amend s. 465.025 as to existing law providing for the authority of physicians to prohibit generic drug substitution by writing “medically necessary” on the prescription.
History.—ss. 1, 2, ch. 2001-146.
Notes of Decisions
Cited in 1
case, 2009–2009 · leading case: Abbott Laboratories v. Mylan Pharmaceuticals, Inc.
Abbott Laboratories v. Mylan Pharmaceuticals, Inc. (2009)
“” Section 465.0251, Florida Statutes (2007), permits removal from the NDF under specific circumstances and states: 465.”
— 465.0251(1) — 1 case
Abbott Laboratories v. Mylan Pharmaceuticals, Inc. (2009)
“” Section 465.0251, Florida Statutes (2007), permits removal from the NDF under specific circumstances and states: 465.”
Annotations are extracted automatically from the opinions in the
Syfert caselaw corpus and ranked by authority, recency, and
treatment. Dots show Syfertize treatment of the citing case itself.